Suppr超能文献

聚乙二醇和D-肽的口服生物利用度所反映的细胞旁途径中大小辨别方面的物种差异。

Species differences in size discrimination in the paracellular pathway reflected by oral bioavailability of poly(ethylene glycol) and D-peptides.

作者信息

He Y L, Murby S, Warhurst G, Gifford L, Walker D, Ayrton J, Eastmond R, Rowland M

机构信息

School of Pharmacy and Pharmaceutical Sciences and the Department of Medicine, University of Manchester, Manchester M13 9PL UK.

出版信息

J Pharm Sci. 1998 May;87(5):626-33. doi: 10.1021/js970120d.

Abstract

Animal models are frequently used to aid prediction of intestinal absorption in humans. However, there is little comparative quantitative information on species differences in paracellular permeation, which is an important route for oral absorption of small to medium-sized hydrophilic drug molecules. This study addresses this issue by comparing the molecular mass (MM) dependency in oral bioavailability between rat and dog of poly(ethylene glycol) (PEG), a polydispersed model mixture commonly used to characterize paracellular absorption, and of a series of eight D-peptides (based on D-phenylalanine). Fasted rats and dogs received PEG (400/900) and the D-peptides (MM 236-406 Da), orally and intravenously, with total 24-48 h urine collection to estimate oral bioavailability. After HPLC separation, the individual PEG oligomers and D-peptides were determined using radiometric detection, for radiolabeled material, and LC-MS, for unlabeled (PEG) material. All compounds were predominantly excreted unchanged following intravenous administration. After oral administration, the predominant peak in the radiochromatogram was unchanged material, indicating stability of the compounds in the gastrointestinal tract. A clear molecular mass dependency in oral bioavailability was seen with both series, but with absorption much greater in dog than rat. Thus, for PEG in rat, bioavailability decreased sharply from 79 to around 2% with increasing MM between 282 and 591 Da, and then tapered to around 1. 5% up to 1295 Da. Whereas in dog, bioavailability remained around 100% for oligomers up to 600 Da and then decreased quite sharply with increasing MM, tending to plateau around 13% beyond 900 Da. Likewise, for the d-peptides in rat, bioavailability decreased from 30 to 1% with increasing MM between 236 and 406 Da, whereas in dog it was 100%, declining to 16% over the same molecular range. This species difference appears to be due to a larger pore size and greater frequency of pores in the paracellular pathway of dog compared to rat. Furthermore, on the basis of comparison with literature data for PEG and selected drugs, rat would appear to be a better predictor than dog of absorption of hydrophilic compounds in human.

摘要

动物模型常被用于辅助预测人体肠道吸收情况。然而,关于细胞旁路渗透的种间差异,目前几乎没有比较性的定量信息,而细胞旁路渗透是中小尺寸亲水性药物分子口服吸收的重要途径。本研究通过比较聚乙二醇(PEG)(一种常用于表征细胞旁路吸收的多分散模型混合物)以及一系列8种D-肽(基于D-苯丙氨酸)在大鼠和犬口服生物利用度方面的分子量(MM)依赖性,来解决这一问题。禁食的大鼠和犬经口和静脉给予PEG(400/900)和D-肽(分子量236 - 406 Da),收集24 - 48小时的尿液以估算口服生物利用度。经高效液相色谱(HPLC)分离后,对于放射性标记物质,使用放射性检测法测定各个PEG低聚物和D-肽;对于未标记的(PEG)物质,使用液相色谱 - 质谱联用(LC - MS)法测定。静脉给药后,所有化合物大多以原形排泄。口服给药后,放射色谱图中的主要峰为未变化的物质,表明这些化合物在胃肠道中稳定。两个系列均观察到口服生物利用度与分子量有明显的依赖性,但犬的吸收比大鼠大得多。因此,对于大鼠体内的PEG,随着分子量在282至591 Da之间增加,生物利用度从79%急剧下降至约2%,然后逐渐下降至约1.5%,直至分子量达到1295 Da。而在犬体内,分子量高达600 Da的低聚物的生物利用度仍保持在约100%,然后随着分子量增加而急剧下降,分子量超过900 Da后趋于稳定在约13%。同样,对于大鼠体内的D-肽,随着分子量在236至406 Da之间增加,生物利用度从30%降至1%,而在犬体内为100%,在相同分子量范围内降至16%。这种种间差异似乎是由于与大鼠相比,犬的细胞旁路途径孔径更大且孔隙频率更高。此外,基于与PEG和选定药物的文献数据比较,大鼠似乎比犬更能预测人体中亲水性化合物的吸收情况。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验